Feline Osteoarthritis: Solensia is Coming to Help!
Technical Bulletin by Sorrel Langley-Hobbs, MA BVetMed, DSAS(O), DipECVS, FHEA, MRCVS
& Dr Edwina Gildea MVB, MRCVS
You can view this information at https://www.zoetisus.com/oa-pain/img/pdf/sorell-feline-oa-pain-technical-bulletin.pdf
- Osteoarthritis is very common, 50% of all cats present with clinical signs and more than 90% of cats older than 12 will show radiographic evidence of osteoarthritis.
- Osteoarthritis can be found in cats as young as two years old.
- Osteoarthritis is the most commonly diagnosed form of degenerative joint disease, implying damage to the appendicular and axial skeletal systems.
- Osteoarthritis can present as hesitation to jump up or down, reduced mobility, hesitation to use steps, decreased grooming, and sensitivity to petting or touching.
- Nutraceuticals, diets, weight reduction (if indicated), environmental modification, exercise, and physical therapy can all assist with treating osteoarthritis.
Our friends at Zoetis have been working on a new medication to help with osteoarthritis! This medication is called Solensia and is slated to release late in 2022.
- Solensia is a once a month injectable monoclonal antibody therapy for osteoarthritis control.
- 77% of cat owners reported improvements in osteoarthritis related pain when treated once a month for 3 months!
- Solensia was well tolerated in field studies that included cats with IRIS stage 1 or 2 renal disease
To learn more about Solensia, visit their website here: https://www.zoetispetcare.com/products/solensia
Written by: Morgan Guiffre
